Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Lung Cancer (I and II)”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Not applicableUnknownNCT06341387
What this trial is testing

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage II+1 more
European Institute of Oncology 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)UnknownNCT00519805
What this trial is testing

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Who this might be right for
Lung CancerThromboembolism
Velindre NHS Trust 2,200
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT06140407
What this trial is testing

Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Lung Small Cell CarcinomaStage I Lung CancerStage II Lung Cancer+1 more
Vanderbilt-Ingram Cancer Center 1
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Testing effectiveness (Phase 2)UnknownNCT04834089
What this trial is testing

Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases

Who this might be right for
ImmunosuppressionCancerCOVID-19+6 more
Butantan Institute 618
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Large-scale testing (Phase 3)Study completedNCT00031785
What this trial is testing

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Who this might be right for
AnorexiaCachexiaLung Cancer
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04716946
What this trial is testing

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer+5 more
Memorial Sloan Kettering Cancer Center 13
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Early research (Phase 1)Study completedNCT00019006
What this trial is testing

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

Who this might be right for
Recurrent Colon CancerExtensive Stage Small Cell Lung CancerStage III Pancreatic Cancer+11 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01294280
What this trial is testing

Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 241
Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Load More Results